Described herein are pharmaceutical packaging systems which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate medications, these types of programs like a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very small permeability to oxygen and compri